Showing results (101-110 of 216) with videos related to
Sort By:
Pageof 22
Journal for Immunotherapy of Cancer|September 1, 2020
Immune-related pneumonitis associated with immune checkpoint inhibitors in lung cancer: a network meta-analysisXinru Chen, Zhonghan Zhang, Xue Hou, et al.Medcomm|July 10, 2025
Phase I Clinical Trial of CVL218, a Novel PARP1/2 Inhibitor, in Patients with Advanced Solid TumorsZihong Chen, Gang Chen, Yuxiang Ma, et al.Cancer|October 5, 2022
Comparison of aprepitant versus desloratadine for EGFR-TKI-induced pruritus: A randomized phase 2 clinical trialTing Zhou, Yaxiong Zhang, Yuxiang Ma, et al.Scientific Reports|June 19, 2015
Ratio of C-Reactive Protein/Albumin is An Inflammatory Prognostic Score for Predicting Overall Survival of Patients with Small-cell Lung CancerTing Zhou, Jianhua Zhan, Shaodong Hong, et al.Journal of the National Cancer Institute|November 1, 2016
Neurokinin-1 Receptor Antagonist-Based Triple Regimens in Preventing Chemotherapy-Induced Nausea and Vomiting: A Network Meta-AnalysisYaxiong Zhang, Yunpeng Yang, Zhonghan Zhang, et al.Translational Lung Cancer Research|June 19, 2025
Evaluating the tumor response assessment of modified-RECIST 1.1 in advance non-small cell lung cancer: a <i>post-hoc</i> analysis of 1,147 patients from the EAST-LC trialQun Chen, Wenwen Huang, Gang Chen, et al.Signal Transduction and Targeted Therapy|September 26, 2024
Surufatinib plus toripalimab combined with etoposide and cisplatin as first-line treatment in advanced small-cell lung cancer patients: a phase Ib/II trialYaxiong Zhang, Yan Huang, Yunpeng Yang, et al.International Journal of Nanomedicine|September 20, 2019
Cell penetrating peptide-modified nanoparticles for tumor targeted imaging and synergistic effect of sonodynamic/HIFU therapyYizhen Li, Lan Hao, Fengqiu Liu, et al.ACS Applied Materials & Interfaces|June 13, 2015
Magnetic Hyperthermia Ablation of Tumors Using Injectable Fe₃O₄/Calcium Phosphate CementChunyan Xu, Yuanyi Zheng, Wei Gao, et al.Journal for Immunotherapy of Cancer|December 23, 2018
Immune-checkpoint inhibitor plus chemotherapy versus conventional chemotherapy for first-line treatment in advanced non-small cell lung carcinoma: a systematic review and meta-analysisYixin Zhou, Chen Chen, Xuanye Zhang, et al.Pageof 22